| | 1929519-13-0 Basic information More.. |
| Product Name: | TAK-041 | | Synonyms: | TAK-041;NBI-1065846;TAK-041 (Synonyms: NBI-1065846);(S)-2-(4-Oxobenzo[d][1,2,3]triazin-3(4H)-yl)-N-(1-(4-(trifluoromethoxy)phenyl)ethyl)acetamide;inhibit,deficits,social,BALB/c,NBI 1065846,NBI1065846,negative,schizophrenia,TAK-041,GPR139,symptoms,interaction,G Protein-Coupled Receptor 139,TAK 041,mouse,TAK041,Inhibitor;1,2,3-Benzotriazine-3(4H)-acetamide, 4-oxo-N-[(1S)-1-[4-(trifluoromethoxy)phenyl]ethyl]-;Zelatriazin;2-(4-oxo-3,4-dihydro-1,2,3-benzotriazin-3-yl)-N-[(1S)-1-[4-(trifluoromethoxy)phenyl]ethyl]acetamide | | CAS: | 1929519-13-0 | | MF: | C18H15F3N4O3 | | MW: | 392.33 | | EINECS: | | | Mol File: | 1929519-13-0.mol |  |
TAK-041 manufacturers
- TAK-041
-
- US $31.00-237.00 / mg
- 2025-08-29
- CAS:1929519-13-0
- Min. Order:
- Purity: 99.95%
- Supply Ability: 10g
|
|
1929519-13-0
Recommend Suppliers |
|